A novel dual NO-donating oxime and c-Jun N-terminal kinase inhibitor protects against cerebral ischemia–reperfusion injury in mice

Détails bibliographiques
Parent link:Neuroscience Letters.— , 1975-
Vol. 618.— 2016.— [P. 45–49]
Collectivités auteurs: Национальный исследовательский Томский политехнический университет Управление проректора по научной работе и инновациям Центр RASA в Томске Лаборатория изучения механизмов нейропротекции, Национальный исследовательский Томский политехнический университет Институт физики высоких технологий Кафедра биотехнологии и органической химии
Autres auteurs: Atochin D. N. Dmitry Nikolaevich, Schepetkin (Shchepyotkin) I. A. Igor Aleksandrovich, Khlebnikov A. I. Andrey Ivanovich, Seledtsov V. I. Victor I., Swanson H. Helen, Quinn M. T. Mark T., Huang P. L. Paul L.
Résumé:Title screen
The c-Jun N-terminal kinase (JNK) has been shown to be an important regulator of neuronal cell death. Previously, we synthesized the sodium salt of 11H-indeno[1,2-b]quinoxalin-11-one (IQ-1S) and demonstrated that it was a high-affinity inhibitor of the JNK family. In the present work, we found that IQ-1S could release nitric oxide (NO) during its enzymatic metabolism by liver microsomes. Moreover, serum nitrite/nitrate concentration in mice increased after intraperitoneal injection of IQ-1S. Because of these dual actions as JNK inhibitor and NO-donor, the therapeutic potential of IQ-1S was evaluated in an animal stroke model. We subjected wild-type C57BL6 mice to focal ischemia (30 min) with subsequent reperfusion (48 h). Mice were treated with IQ-1S (25 mg/kg) suspended in 10% solutol or with vehicle alone 30 min before and 24 h after middle cerebral artery (MCA) occlusion (MCAO). Using laser-Doppler flowmetry, we monitored cerebral blood flow (CBF) above the MCA during 30 min of MCAO provoked by a filament and during the first 30 min of subsequent reperfusion. In mice treated with IQ-1S, ischemic and reperfusion values of CBF were not different from vehicle-treated mice. However, IQ-1S treated mice demonstrated markedly reduced neurological deficit and infarct volumes as compared with vehicle-treated mice after 48 h of reperfusion. Our results indicate that the novel JNK inhibitor releases NO during its oxidoreductive bioconversion and improves stroke outcome in a mouse model of cerebral reperfusion. We conclude that IQ-1S is a promising dual functional agent for the treatment of cerebral ischemia and reperfusion injury.
Режим доступа: по договору с организацией-держателем ресурса
Langue:anglais
Publié: 2016
Sujets:
Accès en ligne:http://dx.doi.org/10.1016/j.neulet.2016.02.033
Format: Électronique Chapitre de livre
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=648023

MARC

LEADER 00000naa0a2200000 4500
001 648023
005 20250219100007.0
035 |a (RuTPU)RU\TPU\network\13180 
035 |a RU\TPU\network\13150 
090 |a 648023 
100 |a 20160505d2016 k||y0rusy50 ba 
101 0 |a eng 
102 |a IE 
135 |a drcn ---uucaa 
181 0 |a i  
182 0 |a b 
200 1 |a A novel dual NO-donating oxime and c-Jun N-terminal kinase inhibitor protects against cerebral ischemia–reperfusion injury in mice  |f D. N. Atochin, I. A. Schepetkin (Shchepyotkin), A. I. Khlebnikov [et al.] 
203 |a Text  |c electronic 
300 |a Title screen 
320 |a [References.: p. 49 (45 tit.)] 
330 |a The c-Jun N-terminal kinase (JNK) has been shown to be an important regulator of neuronal cell death. Previously, we synthesized the sodium salt of 11H-indeno[1,2-b]quinoxalin-11-one (IQ-1S) and demonstrated that it was a high-affinity inhibitor of the JNK family. In the present work, we found that IQ-1S could release nitric oxide (NO) during its enzymatic metabolism by liver microsomes. Moreover, serum nitrite/nitrate concentration in mice increased after intraperitoneal injection of IQ-1S. Because of these dual actions as JNK inhibitor and NO-donor, the therapeutic potential of IQ-1S was evaluated in an animal stroke model. We subjected wild-type C57BL6 mice to focal ischemia (30 min) with subsequent reperfusion (48 h). Mice were treated with IQ-1S (25 mg/kg) suspended in 10% solutol or with vehicle alone 30 min before and 24 h after middle cerebral artery (MCA) occlusion (MCAO). Using laser-Doppler flowmetry, we monitored cerebral blood flow (CBF) above the MCA during 30 min of MCAO provoked by a filament and during the first 30 min of subsequent reperfusion. In mice treated with IQ-1S, ischemic and reperfusion values of CBF were not different from vehicle-treated mice. However, IQ-1S treated mice demonstrated markedly reduced neurological deficit and infarct volumes as compared with vehicle-treated mice after 48 h of reperfusion. Our results indicate that the novel JNK inhibitor releases NO during its oxidoreductive bioconversion and improves stroke outcome in a mouse model of cerebral reperfusion. We conclude that IQ-1S is a promising dual functional agent for the treatment of cerebral ischemia and reperfusion injury. 
333 |a Режим доступа: по договору с организацией-держателем ресурса 
461 |t Neuroscience Letters  |d 1975- 
463 |t Vol. 618  |v [P. 45–49]  |d 2016 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
701 1 |a Atochin  |b D. N.  |c neuroscientist  |c The Head of the Laboratory of Tomsk Polytechnic University  |f 1960-  |g Dmitry Nikolaevich  |3 (RuTPU)RU\TPU\pers\37514  |9 20383 
701 1 |a Schepetkin (Shchepyotkin)  |b I. A.  |c doctor-biophysicist  |c leading researcher of Tomsk Polytechnic University, candidate of medical science  |f 1962-  |g Igor Aleksandrovich  |3 (RuTPU)RU\TPU\pers\37358  |9 20276 
701 1 |a Khlebnikov  |b A. I.  |c Chemist  |c Professor of Tomsk Polytechnic University  |f 1963-  |g Andrey Ivanovich  |3 (RuTPU)RU\TPU\pers\33927  |9 17500 
701 1 |a Seledtsov  |b V. I.  |g Victor I. 
701 1 |a Swanson  |b H.  |g Helen 
701 1 |a Quinn  |b M. T.  |g Mark T. 
701 1 |a Huang  |b P. L.  |g Paul L. 
712 0 2 |a Национальный исследовательский Томский политехнический университет  |b Управление проректора по научной работе и инновациям  |b Центр RASA в Томске  |b Лаборатория изучения механизмов нейропротекции  |9 28136 
712 0 2 |a Национальный исследовательский Томский политехнический университет  |b Институт физики высоких технологий  |b Кафедра биотехнологии и органической химии  |3 (RuTPU)RU\TPU\col\18693  |9 27146 
801 2 |a RU  |b 63413507  |c 20201103  |g RCR 
856 4 |u http://dx.doi.org/10.1016/j.neulet.2016.02.033 
942 |c CF